IA
HALO icon

IFP Advisors’s Halozyme HALO Stock Holding History

IFP Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,000
Closed -$13K – 4138
2017
Q1 		$13K Buy
+1,000
New +$12.6K ﹤0.01% 2769

Other funds holding HALO

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

IFP Advisors's HALO Position: Q2 2026 in Review

IFP Advisors increased its Halozyme (HALO) stake by 9% in Q2 2026, buying an estimated $22.1K and bringing the position to 3,939 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #1275.

IFP Advisors first reported a position in HALO in Q4 2015 and has held it in 32 quarters since. The position peaked at $382K in Q3 2025. 156 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • IFP Advisors held 3,939 shares of Halozyme worth $308K as of Q2 2026.
  • IFP Advisors bought 324 Halozyme shares in Q2 2026, an estimated $22.1K.
  • Halozyme made up 0.01% of IFP Advisors's portfolio in Q2 2026, its #1275 holding.
  • IFP Advisors first reported a position in Halozyme in Q4 2015 and has held it in 32 quarters since.
  • IFP Advisors's Halozyme position peaked at $382K in Q3 2025.
  • 156 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.